XML 41 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Shareholder's Equity - SB/RH - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Total Shareholders' Equity
Total Shareholders' Equity
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Earnings (Deficit)
Accumulated Earnings (Deficit)
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Cumulative Effect, Period of Adoption, Adjustment
Non- controlling Interest
SB/RH
SB/RH
Cumulative Effect, Period of Adoption, Adjustment
SB/RH
Total Shareholders' Equity
SB/RH
Total Shareholders' Equity
Cumulative Effect, Period of Adoption, Adjustment
SB/RH
Other Capital
SB/RH
Accumulated Earnings (Deficit)
SB/RH
Accumulated Earnings (Deficit)
Cumulative Effect, Period of Adoption, Adjustment
SB/RH
Accumulated Other Comprehensive Loss
SB/RH
Accumulated Other Comprehensive Loss
Cumulative Effect, Period of Adoption, Adjustment
SB/RH
Non- controlling Interest
Balance at beginning of period at Sep. 30, 2019 $ 1,728.9 $ 0.0 $ 1,720.9 $ 0.0 $ 223.8 $ (0.3) $ (273.6) $ 0.3 $ 8.0 $ 1,434.7 $ 0.0 $ 1,425.1 $ 0.0 $ 2,113.3 $ (414.7) $ (0.3) $ (273.5) $ 0.3 $ 9.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Net (loss) income from continuing operations (52.4)   (52.7)   (52.7)       0.3 (108.4)   (108.7)     (108.7)       0.3
Income (loss) from discontinued operations, net of tax 150.9   150.5   150.5       0.4 150.9   150.5     150.5       0.4
Sale and deconsolidation of discontinued operations and assets held for sale (8.1)   (8.1)       (8.1)     (8.1)   (8.1)         (8.1)    
Other comprehensive (loss) income, net of tax (19.1)   (19.5)       (19.5)   0.4 (19.1)   (19.5)         (19.5)   0.4
Restricted stock issued and related tax withholdings 4.8   4.8   0.0         4.5   4.5   4.5          
Share based compensation 37.6   37.6             36.3   36.3   36.3          
Dividends paid (77.4)   (77.4)   (77.4)         (241.0)   (241.0)     (241.0)        
Dividend paid by subsidiary to NCI (0.8)               (0.8) (0.8)                 (0.8)
Balance at end of period at Sep. 30, 2020 1,415.8   1,407.5   243.9   (284.7)   8.3 1,265.2   1,255.3   2,154.1 (614.2)   (284.6)   9.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Net (loss) income from continuing operations 15.3   15.1   15.1       0.2 17.3   17.1     17.1       0.2
Income (loss) from discontinued operations, net of tax 174.3   174.5   174.5       (0.2) 174.3   174.5     174.5       (0.2)
Sale and deconsolidation of discontinued operations and assets held for sale 0.0                 0.0                  
Other comprehensive (loss) income, net of tax 49.8   49.4       49.4   0.4 49.8   49.4         49.4   0.4
Restricted stock issued and related tax withholdings (4.9)   (4.9)             (7.3)   (7.3)   (7.3)          
Share based compensation 29.7   29.7             28.0   28.0   28.0          
Dividends paid (73.6)   (73.6)   (73.6)         (192.3)   (192.3)     (192.3)        
Dividend paid by subsidiary to NCI (1.6)               (1.6) (1.6)                 (1.6)
Balance at end of period at Sep. 30, 2021 1,479.0   1,471.9   359.9   (235.3)   7.1 1,333.4   1,324.7   2,174.8 (614.9)   (235.2)   8.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Net (loss) income from continuing operations (77.0)   (77.2)   (77.2)       0.2 (75.0)   (75.2)     (75.2)       0.2
Income (loss) from discontinued operations, net of tax 149.7   148.8   148.8       0.9 149.7   148.8     148.8       0.9
Sale and deconsolidation of discontinued operations and assets held for sale 0.0                 0.0                  
Other comprehensive (loss) income, net of tax (68.7)   (67.8)       (67.8)   (0.9) (68.7)   (67.8)         (67.8)   (0.9)
Restricted stock issued and related tax withholdings (24.5)   (24.5)             (24.5)   (24.5)   (24.5)          
Share based compensation 15.4   15.4             14.3   14.3   14.3          
Dividends paid (69.4)   (69.4)   (69.4)         (194.7)   (194.7)     (194.7)        
Dividend paid by subsidiary to NCI (1.4)               (1.4) (1.4)                 (1.4)
Balance at end of period at Sep. 30, 2022 $ 1,269.1   $ 1,263.2   $ 362.1   $ (303.1)   $ 5.9 $ 1,133.1   $ 1,125.6   $ 2,164.6 $ (736.0)   $ (303.0)   $ 7.5